Halozyme Therapeutics Inc. buy Morgan Stanley
Start price
06.03.23
/
50%
€42.50
Target price
06.03.24
€60.06
Performance (%)
-10.61%
End price
07.03.24
€37.99
Summary
This prediction ended on 07.03.24 with a price of €37.99. The price of Halozyme Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.61%. Morgan_Stanley has a follow-up prediction for Halozyme Therapeutics Inc. where he still thinks Halozyme Therapeutics Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Halozyme Therapeutics Inc. | 4.955% | 4.955% | 36.393% |
| iShares Core DAX® | 2.831% | 1.236% | 14.788% |
| iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% |
| iShares Nikkei 225® | 2.007% | -2.135% | 19.861% |
| iShares S&P 500 | 2.257% | 0.451% | 30.090% |
Comments by Morgan_Stanley for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target lowered by analysts at Morgan Stanley from $65.00 to $64.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat
In the thread Trading Halozyme Therapeutics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€40.11
10.08.23
10.08.23
€55.35
10.08.24
10.08.24
0.80%
16:37
16:37
Stopped prediction by Morgan_Stanley for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.03
26.12.23
26.12.23
€53.50
26.12.24
26.12.24
18.81%
16:37
16:37